Your browser is not supported

Your browser is too old. To use this website, please use Chrome or Firefox.

Entire people groups still have NO ACCESS to the transforming gospel of the love of God. 

4.5 billion people don’t have access to the Word of God.1

3.1 billion people worldwide are without access to a church that preaches the gospel in their language or in a culturally relevant way.2

Over 2 million villages and neighbourhoods still have no church.1

 

STEP OUT.  

 

The obstacles that prevent communities from embracing the good news are real, but by the grace of God, they are not insurmountable. It is at this intersection of opportunities and obstacles that we watch, pray and go with eager expectation that God will intervene.

Christar wants to challenge you to STEP OUT!
STEP OUT in faith onto the path the Lord is taking you on.
STEPPING-OUT comes in many shapes and sizes, it looks different
for everyone. It might come in the form of knocking on your neighbour’s door or it might be that the Lord is asking you to go to the least reached in a far-off country.

The challenge is simple, STEP OUT! We would love to hear your STEP OUT stories, pray for you, and rejoice with you.

Fill in the form below and talk with us, or let us know how we can help you in this journey! 

STEP OUT
First
Last

Christar is committed to creatively and effectively establishing churches that are rooted in the Word of God and upheld with prayer. As the body of Christ goes to these places that are still without access to the good news, seeds of the gospel are planted and nurtured. New believers are discipled and trained until mature. And indigenous churches grow to represent Christ and His transforming work in these communities and those around them.

And so the cycle of transformation continues, but it always begins with God—intervening, calling, saving and sending. We stand at the crossroads with hopeful anticipation. We STEP OUT to be used by God to help see this transformation take place where the gospel is not yet fully proclaimed.